Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

62.73
Delayed Data
As of 4:00pm ET
 -0.85 / -1.34%
Today’s Change
45.69
Today|||52-Week Range
64.00
+18.76%
Year-to-Date
Healthcare Drug Pricing a Factor for the Market on Wednesday
6:13pm / GuruFocus News - Paid Partner Content
How Will Merck (MRK) Stock React to Potential Medivation Bid?
Aug 17 / TheStreet.com - Paid Partner Content
Merck Offers Value and Steady Dividend Growth
3:56pm / GuruFocus News - Paid Partner Content
Gilead: breaking the fever
Aug 17 / FT.com - Paid Partner Content
Merck Potential Blockbuster Drug, Key Acquisition Make It a Good Bet for Investors
Aug 23 / TheStreet.com - Paid Partner Content
Pfizer's Bold Bid to Conquer Cancer
Aug 16 / MotleyFool.com - Paid Partner Content
ETFs in Focus on Pfizer's Medivation Acquisition
Aug 22 / Zacks.com - Paid Partner Content
Stocks are hot again. But are they too hot?
Aug 16 / CNNMoney.com
2 Cancer Therapy Stocks That Are Ridiculously Cheap Right Now
Aug 18 / MotleyFool.com - Paid Partner Content
Inovio Expands Enrollment in Ebola Vaccine Phase I Study
Aug 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close63.58
Today’s open63.54
Day’s range62.51 - 63.78
Volume7,477,273
Average volume (3 months)9,461,248
Market cap$175.8B
Dividend yield2.93%
Data as of 4:00pm ET, 08/24/2016

Growth & Valuation

Earnings growth (last year)-61.67%
Earnings growth (this year)+4.17%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)-7.92%
P/E ratio34.5
Price/Sales3.87
Price/Book3.96

Competitors

 Today’s
change
Today’s
% change
AGNPRAAllergan plc-27.26-3.08%
NVSNovartis-1.06-1.30%
PFEPfizer-0.27-0.77%
GSKGlaxoSmithKline-0.51-1.15%
Data as of 4:02pm ET, 08/24/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$0.98
Annual revenue (last year)$38.8B
Annual profit (last year)$4.4B
Net profit margin11.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts

Partner Offers

Search for Jobs